Login to Your Account

3Q 2017 analysis

Biopharmaceutical companies able to generate almost $16B in Q3

By Peter Winter

Monday, October 9, 2017

The amount of cash generated by global public and private biopharmaceutical companies was up significantly in the third quarter compared to the second quarter. The almost $16 billion haul was 45 percent higher than the $11 billion raised during the second quarter and almost 25 percent higher than the total generated in the same period last year. Thanks to their higher company valuations, public companies were able to conduct public offerings with confidence, and the amount of private capital raised ballooned to more than $3.23 billion – a 61 percent increase over the $2 billion generated in the second quarter of this year.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription